187 related articles for article (PubMed ID: 33020149)
21. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI.
Zakowicz H; Yang HS; Stark C; Wlodawer A; Laronde-Leblanc N; Colburn NH
RNA; 2005 Mar; 11(3):261-74. PubMed ID: 15661843
[TBL] [Abstract][Full Text] [Related]
22. The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss.
O'Bryant D; Wang Z
Oncogene; 2018 Jul; 37(30):4151-4163. PubMed ID: 29706654
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer.
Wang C; Leavenworth J; Zhang C; Liu Z; Yuan KY; Wang Y; Zhang G; Wang S; Cui X; Zhang Y; Bae S; Zhou J; Wang L; Liu R
Oncogene; 2022 May; 41(19):2778-2785. PubMed ID: 35361883
[TBL] [Abstract][Full Text] [Related]
24. Evidence That Base-pairing Interaction between Intron and mRNA Leader Sequences Inhibits Initiation of HAC1 mRNA Translation in Yeast.
Sathe L; Bolinger C; Mannan MA; Dever TE; Dey M
J Biol Chem; 2015 Sep; 290(36):21821-32. PubMed ID: 26175153
[TBL] [Abstract][Full Text] [Related]
25. Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.
Thompson PA; Eam B; Young NP; Fish S; Chen J; Barrera M; Howard H; Sung E; Parra A; Staunton J; Chiang GG; Gerson-Gurwitz A; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Xiang A; Nilewski C; Packard GK; Michels T; Tran C; Sprengeler PA; Ernst JT; Reich SH; Webster KR
Mol Cancer Ther; 2021 Jan; 20(1):26-36. PubMed ID: 33037136
[TBL] [Abstract][Full Text] [Related]
26. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
Raza F; Waldron JA; Quesne JL
Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.
Han R; Zhao J; Lu L
Oncol Rep; 2020 Jun; 43(6):2062-2072. PubMed ID: 32186770
[TBL] [Abstract][Full Text] [Related]
28. Regulation of eukaryotic protein synthesis: selective influenza viral mRNA translation is mediated by the cellular RNA-binding protein GRSF-1.
Park YW; Wilusz J; Katze MG
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6694-9. PubMed ID: 10359774
[TBL] [Abstract][Full Text] [Related]
29. eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes.
Waldron JA; Raza F; Le Quesne J
Nucleic Acids Res; 2018 Apr; 46(6):3075-3087. PubMed ID: 29471358
[TBL] [Abstract][Full Text] [Related]
30. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
Sheng X; Bowen N; Wang Z
Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
[TBL] [Abstract][Full Text] [Related]
31. Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts.
Wang H; Wang X; Xu L; Zhang J
BMC Pediatr; 2022 Jun; 22(1):376. PubMed ID: 35764946
[TBL] [Abstract][Full Text] [Related]
32. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains.
Suzuki C; Garces RG; Edmonds KA; Hiller S; Hyberts SG; Marintchev A; Wagner G
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3274-9. PubMed ID: 18296639
[TBL] [Abstract][Full Text] [Related]
33. The role of the 5' untranslated region of an mRNA in translation regulation during development.
van der Velden AW; Thomas AA
Int J Biochem Cell Biol; 1999 Jan; 31(1):87-106. PubMed ID: 10216946
[TBL] [Abstract][Full Text] [Related]
34. MDM2's dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities.
Gnanasundram SV; Malbert-Colas L; Chen S; Fusée L; Daskalogianni C; Muller P; Salomao N; Fåhraeus R
Nucleic Acids Res; 2020 Jul; 48(12):6775-6787. PubMed ID: 32453417
[TBL] [Abstract][Full Text] [Related]
35. Splicing factor SRSF3 represses the translation of programmed cell death 4 mRNA by associating with the 5'-UTR region.
Kim J; Park RY; Chen JK; Kim J; Jeong S; Ohn T
Cell Death Differ; 2014 Mar; 21(3):481-90. PubMed ID: 24292556
[TBL] [Abstract][Full Text] [Related]
36. Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity.
Qi H; Shi X; Yu M; Liu B; Liu M; Song S; Chen S; Zou J; Zhu WG; Luo J
J Biol Chem; 2018 Nov; 293(46):17769-17779. PubMed ID: 30282801
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor compensation during mammary gland development in E2F knockout mice.
To B; Andrechek ER
PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
[TBL] [Abstract][Full Text] [Related]
38. Translational regulation via 5' mRNA leader sequences revealed by mutational analysis of the Arabidopsis translation initiation factor subunit eIF3h.
Kim TH; Kim BH; Yahalom A; Chamovitz DA; von Arnim AG
Plant Cell; 2004 Dec; 16(12):3341-56. PubMed ID: 15548739
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regions.
Steinberger J; Shen L; J Kiniry S; Naineni SK; Cencic R; Amiri M; Aboushawareb SAE; Chu J; Maïga RI; Yachnin BJ; Robert F; Sonenberg N; Baranov PV; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(17):9521-9537. PubMed ID: 32766783
[TBL] [Abstract][Full Text] [Related]
40. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis.
Bashari D; Hacohen D; Ginsberg D
Cell Signal; 2011 Jan; 23(1):65-70. PubMed ID: 20800677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
